CMIN relies on two undiscovered channels of mineralization to improve its business development.
Historical data shows that CMIN has traded higher over the past 12 months, when its stock price reached over $1.
The financial results of CMIN don't seem much promising, as the company has not generated any revenues since its inception about ten years ago.
The majority of patients with CMIN tend to be nonoliguric except those with pre-existing advanced chronic renal failure.
A persistent nephrogram on plain radiography or computed tomography (CT) of the abdomen for 24 to 48 hours after contrast media injection has been described as a feature of CMIN.
The development of CMIN is low in people with normal renal function varying from 0% to 2%.
14) The degree of renal insufficiency present before the administration of contrast media determines, to a great extent, the severity of CMIN.